Q32 Bio (QTTB) Cash & Current Investments (2017 - 2025)
Historic Cash & Current Investments for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $68.9 million.
- Q32 Bio's Cash & Current Investments fell 2260.27% to $68.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.9 million, marking a year-over-year decrease of 2260.27%. This contributed to the annual value of $78.0 million for FY2024, which is 20434.87% up from last year.
- As of Q3 2025, Q32 Bio's Cash & Current Investments stood at $68.9 million, which was down 2260.27% from $54.8 million recorded in Q2 2025.
- Q32 Bio's Cash & Current Investments' 5-year high stood at $256.1 million during Q1 2022, with a 5-year trough of $25.6 million in Q4 2023.
- In the last 5 years, Q32 Bio's Cash & Current Investments had a median value of $135.3 million in 2024 and averaged $134.6 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 8536.39% in 2023, then skyrocketed by 20434.87% in 2024.
- Quarter analysis of 5 years shows Q32 Bio's Cash & Current Investments stood at $157.8 million in 2021, then rose by 10.9% to $175.0 million in 2022, then crashed by 85.36% to $25.6 million in 2023, then skyrocketed by 204.35% to $78.0 million in 2024, then decreased by 11.57% to $68.9 million in 2025.
- Its last three reported values are $68.9 million in Q3 2025, $54.8 million for Q2 2025, and $65.5 million during Q1 2025.